BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36602230)

  • 1. Microstructural parameters from DW-MRI for tumour characterization and local recurrence prediction in particle therapy of skull-base chordoma.
    Morelli L; Palombo M; Buizza G; Riva G; Pella A; Fontana G; Imparato S; Iannalfi A; Orlandi E; Paganelli C; Baroni G
    Med Phys; 2023 May; 50(5):2900-2913. PubMed ID: 36602230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving the characterization of meningioma microstructure in proton therapy from conventional apparent diffusion coefficient measurements using Monte Carlo simulations of diffusion MRI.
    Buizza G; Paganelli C; Ballati F; Sacco S; Preda L; Iannalfi A; Alexander DC; Baroni G; Palombo M
    Med Phys; 2021 Mar; 48(3):1250-1261. PubMed ID: 33369744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of tumour microstructure estimation from conventional diffusion MRI and application to skull-base chordoma
    Morelli L; Buizza G; Palombo M; Riva G; Fontana G; Imparato S; Iannalfi A; Orlandi E; Paganelli C; Baroni G
    Annu Int Conf IEEE Eng Med Biol Soc; 2021 Nov; 2021():3761-3764. PubMed ID: 34892054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI-based tumour control probability in skull-base chordomas treated with carbon-ion therapy.
    Buizza G; Molinelli S; D'Ippolito E; Fontana G; Pella A; Valvo F; Preda L; Orecchia R; Baroni G; Paganelli C
    Radiother Oncol; 2019 Aug; 137():32-37. PubMed ID: 31051372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of DW MR imaging in the differentiation of chordomas and chondrosarcomas of the skull base: A 3.0-T MRI study of 105 cases.
    Welzel T; Meyerhof E; Uhl M; Huang K; von Deimling A; Herfarth K; Debus J
    Eur J Radiol; 2018 Aug; 105():119-124. PubMed ID: 30017267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging signal characteristics associated with prognosis of skull base chordoma after gamma knife radiosurgery.
    Hu YS; Lee CC; Wu CA; Lin CJ; Yang HC; Guo WY; Liu KD; Chung WY; Shiau CY; Wu HM
    J Neurooncol; 2023 Jan; 161(1):45-56. PubMed ID: 36565364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revisitation of imaging features of skull base chondrosarcoma in comparison to chordoma.
    Hasegawa H; Shin M; Niwa R; Koizumi S; Yoshimoto S; Shono N; Shinya Y; Takami H; Tanaka S; Umekawa M; Amemiya S; Kin T; Saito N
    J Neurooncol; 2022 Sep; 159(3):581-590. PubMed ID: 35882753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiating skull base chordomas and invasive pituitary adenomas with conventional MRI.
    Gao A; Bai J; Cheng J; Cheng X; Li S; Zhang Z; Zhang Y
    Acta Radiol; 2018 Nov; 59(11):1358-1364. PubMed ID: 29448805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton and carbon ion radiotherapy in skull base chordomas: a prospective study based on a dual particle and a patient-customized treatment strategy.
    Iannalfi A; D'Ippolito E; Riva G; Molinelli S; Gandini S; Viselner G; Fiore MR; Vischioni B; Vitolo V; Bonora M; Ronchi S; Petrucci R; Barcellini A; Mirandola A; Russo S; Vai A; Mastella E; Magro G; Maestri D; Ciocca M; Preda L; Valvo F; Orecchia R
    Neuro Oncol; 2020 Sep; 22(9):1348-1358. PubMed ID: 32193546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive role of Apparent Diffusion Coefficient (ADC) from Diffusion Weighted MRI in patients with sacral chordoma treated with carbon ion radiotherapy (CIRT) alone.
    Preda L; Casale S; Fanizza M; Fiore MR; Viselner G; Paganelli C; Buizza G; Fontana G; Vitolo V; Barcellini A; Baroni G; Fossati P; Valvo F
    Eur J Radiol; 2020 May; 126():108933. PubMed ID: 32171109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a role for conventional MRI and MR diffusion-weighted imaging for distinction of skull base chordoma and chondrosarcoma?
    Müller U; Kubik-Huch RA; Ares C; Hug EB; Löw R; Valavanis A; Ahlhelm FJ
    Acta Radiol; 2016 Feb; 57(2):225-32. PubMed ID: 25722460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric analysis of local failures in skull-base chordoma and chondrosarcoma following pencil beam scanning proton therapy.
    Basler L; Poel R; Schröder C; Bolsi A; Lomax A; Tanadini-Lang S; Guckenberger M; Weber DC
    Radiat Oncol; 2020 Nov; 15(1):266. PubMed ID: 33198810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment outcomes of proton or carbon ion therapy for skull base chordoma: a retrospective study.
    Takagi M; Demizu Y; Nagano F; Terashima K; Fujii O; Jin D; Mima M; Niwa Y; Katsui K; Suga M; Yamashita T; Akagi T; Sakata KI; Fuwa N; Okimoto T
    Radiat Oncol; 2018 Nov; 13(1):232. PubMed ID: 30477528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion-weighted MR imaging including bi-exponential fitting for the detection of recurrent or residual tumour after (chemo)radiotherapy for laryngeal and hypopharyngeal cancers.
    Tshering Vogel DW; Zbaeren P; Geretschlaeger A; Vermathen P; De Keyzer F; Thoeny HC
    Eur Radiol; 2013 Feb; 23(2):562-9. PubMed ID: 22865270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI evaluation of sacral chordoma treated with carbon ion radiotherapy alone.
    Preda L; Stoppa D; Fiore MR; Fontana G; Camisa S; Sacchi R; Ghitti M; Viselner G; Fossati P; Valvo F; Vitolo V; Bonora M; Iannalfi A; Vischioni B; Vai A; Mastella E; Baroni G; Orecchia R
    Radiother Oncol; 2018 Aug; 128(2):203-208. PubMed ID: 29279241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion and perfusion MR parameters to assess preoperative short-course radiotherapy response in locally advanced rectal cancer: a comparative explorative study among Standardized Index of Shape by DCE-MRI, intravoxel incoherent motion- and diffusion kurtosis imaging-derived parameters.
    Fusco R; Sansone M; Granata V; Grimm R; Pace U; Delrio P; Tatangelo F; Botti G; Avallone A; Pecori B; Petrillo A
    Abdom Radiol (NY); 2019 Nov; 44(11):3683-3700. PubMed ID: 30361867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ectopic Recurrence of Skull Base Chordoma after Proton Therapy.
    Santegoeds RGC; Alahmari M; Postma AA; Liebsch NJ; Weber DC; Mammar H; Eekers DBP; Temel Y
    Curr Oncol; 2022 Mar; 29(4):2364-2375. PubMed ID: 35448165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton and carbon ion beam treatment with active raster scanning method in 147 patients with skull base chordoma at the Heidelberg Ion Beam Therapy Center-a single-center experience.
    Mattke M; Ohlinger M; Bougatf N; Harrabi S; Wolf R; Seidensaal K; Welzel T; Röder F; Gerum S; Ellerbrock M; Jäkel O; Haberer T; Herfarth K; Uhl M; Debus J
    Strahlenther Onkol; 2023 Feb; 199(2):160-168. PubMed ID: 36149438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiomics and Dosiomics for Predicting Local Control after Carbon-Ion Radiotherapy in Skull-Base Chordoma.
    Buizza G; Paganelli C; D'Ippolito E; Fontana G; Molinelli S; Preda L; Riva G; Iannalfi A; Valvo F; Orlandi E; Baroni G
    Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33477723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of Simultaneous
    Huang Z; Li X; Wang Z; Meng N; Fu F; Han H; Li D; Bai Y; Wei W; Fang T; Feng P; Yuan J; Yang Y; Wang M
    J Magn Reson Imaging; 2022 Jul; 56(1):63-74. PubMed ID: 34888990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.